AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs

The Medicaid program already receives the lowest drug prices in the US, so the additional savings may be modest, said one professor. Photograph: Elise Amendola/AP

Donald Trump announced a deal with the British-based drugmaker AstraZeneca for a “most-favored-nation” drug-pricing model aimed at making prescription medicines more affordable and avoiding the administration’s tariff threats.

The company will sell some medicines at a discount to the government’s Medicaid health plan in exchange for tariff relief, similar to a drug-pricing pact reached last week with Pfizer.